FFA
CRDF icon

Farther Finance Advisors’s Cardiff Oncology CRDF Stock Holding History

Farther Finance Advisors’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.74K Buy
2,879
+2,878
+287,800% +$4.57K ﹤0.01% 4939
2026
Q1 		$2 Sell
1
-321
-100% -$659 ﹤0.01% 5730
2025
Q4 		$905 Hold
322
– – ﹤0.01% 4936
2025
Q3 		$663 Buy
+322
New +$890 ﹤0.01% 4472

Other funds holding CRDF

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
PRTG
Post Resch Tallon Group Pittsford, New York $145M AUM 25.19% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
SA
Scarborough Advisors Annapolis, Maryland $871M AUM 21.96% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
LWA
Ledgewood Wealth Advisors Exeter, New Hampshire $188M AUM 18.45% 1-Year Est. Return
SNB
Security National Bank Omaha, Nebraska $838M AUM 39.07% 1-Year Est. Return
TCOT
Trust Company of Toledo Holland, Ohio $1.2B AUM 33.38% 1-Year Est. Return
GSWM
Golden State Wealth Management Santa Ana, California $1.1B AUM 27.49% 1-Year Est. Return

Farther Finance Advisors's CRDF Position: Q2 2026 in Review

Farther Finance Advisors increased its Cardiff Oncology (CRDF) stake by 287,800% in Q2 2026, buying an estimated $4.57K and bringing the position to 2,879 shares worth $3.74K. The position accounts for ﹤0.01% of the portfolio, ranked #4939.

Farther Finance Advisors first reported a position in CRDF in Q3 2025 and has held it in 4 quarters since. 15 funds tracked by Wall St. Rank hold CRDF as of Q2 2026.

  • Farther Finance Advisors held 2,879 shares of Cardiff Oncology worth $3.74K as of Q2 2026.
  • Farther Finance Advisors bought 2,878 Cardiff Oncology shares in Q2 2026, an estimated $4.57K.
  • Cardiff Oncology made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #4939 holding.
  • Farther Finance Advisors first reported a position in Cardiff Oncology in Q3 2025 and has held it in 4 quarters since.
  • 15 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.